Mergent, Inc. Announces Changes to the HealthShares(TM) Composite, Enabling Technologies, Autoimmune-Inflammation, Cancer, Cardiology and Neuroscience Indexes - Jun 1 2008 5:29PM

Tuesday, May 06, 2008 4:01 PM

NEW YORK, May 6 /PRNewswire/ -- Mergent, Inc., administrator for theHealthshares(TM) Indexes, a series of 20 underlying indexes for theHealthShares(TM) Exchange Traded Funds, today announced the following changeswith effect from the opening of trade on Friday, May 9, 2008: MasimoCorporation (Nasdaq: MASI) will replace Millennium Pharmaceuticals Inc(Nasdaq: MLNM) in the HealthShares(TM) Composite Index, Quest Diagnostics Inc(NYSE: DGX) will replace Millennium Pharmaceuticals Inc (Nasdaq: MLNM) in theHealthShares(TM) Enabling Technologies Index, Actelion (SWISS: ATLN) willreplace Millennium Pharmaceuticals Inc (Nasdaq: MLNM) in the HealthShares(TM)Autoimmune-Inflammation Index, Fresenius SE (Frankfurt: FME) will replaceMillennium Pharmaceuticals Inc (Nasdaq: MLNM) in the HealthShares(TM) CancerIndex, Actelion (SWISS: ATLN) will replace Millennium Pharmaceuticals Inc(Nasdaq: MLNM) in the HealthShares(TM) Cardiology Index, and Schwarz Pharma AG(Frankfurt: SRZ) will replace Millennium Pharmaceuticals Inc (Nasdaq: MLNM) inthe HealthShares(TM) Neuroscience Index.

Related Stories